Read Swiss pharma concentration and how it enters a portfolio through indices, ETFs and home bias. ## The short answer For a Swiss investor, the useful question is not whether the topic looks attractive in isolation. The useful question is what role it plays in the portfolio, which currency and tax frictions it creates, and whether it improves the overall construction. ## How to read it from Switzerland Start with the function: diversification, income, defensive balance, long-term growth or tactical exposure. Then check instrument, broker, currency, liquidity, documentation and how the position interacts with the rest of the portfolio. ## Practical checklist - Define the role before choosing the instrument. - Check currency exposure and Swiss tax documentation. - Compare the position with what is already in the portfolio. - Avoid changing the whole allocation because of one headline. ## Mistakes to avoid - Buying a theme without checking concentration. - Ignoring currency and custody details. - Confusing a useful instrument with a complete strategy. - Treating a short-term market move as a long-term signal. ## Frequently asked questions ### Is this enough to make an investment decision No. It is a framework for analysis, not personal investment advice. The final decision depends on your objectives, horizon, risk tolerance and tax situation. ### What should be checked first Check portfolio role, currency, tax documents, liquidity and whether the exposure duplicates positions you already hold. ## Further reading - <a href="/en/articles/smim-vs-spi-extra-investir-suisse" class="text-[#1E3A5F] underline font-medium">Swiss market guide</a> - <a href="/en/articles/novartis-action-analyse-investisseur-suisse" class="text-[#1E3A5F] underline font-medium">Choosing a Swiss broker</a> - <a href="/en/articles/zurich-insurance-action-dividende-suisse" class="text-[#1E3A5F] underline font-medium">ETF investing from Switzerland</a>